The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I trial of cremophor-free, polymeric micelle formulation of paclitaxel with carboplatin in patients with advanced epithelial ovarian cancer.
Y. Kim
No relevant relationships to disclose
S. W. Lee
No relevant relationships to disclose
S. Kim
No relevant relationships to disclose
Y. Kim
No relevant relationships to disclose
B. Kim
No relevant relationships to disclose
S. Kang
No relevant relationships to disclose